NCT06325683 2026-04-15
Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
National Cancer Institute (NCI)
Phase 2 Suspended
Clinical Trials
12 trialsNCT05432804 2026-04-13
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
National Cancer Institute (NCI)
Phase 1/2 Suspended
NCT06860594 2026-04-13
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
National Cancer Institute (NCI)
Phase 1 Suspended
NCT06129760 2026-04-08
Glioblastoma Remote Monitoring and Care - Research Protocol
Case Comprehensive Cancer Center
Phase NA Suspended
NCT05139056 2026-03-27
Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas
City of Hope Medical Center
Phase 1 Suspended
NCT04677049 2026-01-02
Study of Niacin in Glioblastoma
AHS Cancer Control Alberta
Phase 1/2 Suspended
NCT05183204 2025-12-18
Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma
Weill Medical College of Cornell University
Phase 2 Suspended
NCT06806228 2025-11-19
Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)
Petrov, Andrey
Phase 1 Suspended
NCT04657146 2025-11-12
LAMB-G
Duke University
Suspended
NCT05934630 2025-08-11
Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors
Pediatric Brain Tumor Consortium
Suspended
NCT05513859 2025-06-03
Investigational Imaging Technique During Brain Surgery
Emory University
Phase NA Suspended
NCT05695976 2025-05-28
GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM
Duke University
Suspended